Chuang Yi Biotech (CYBiotech) specializes in researching and developing, and marketing of self-paid medicines and health supplements that improves the customer's quality of life (QOL). The current Taiwan National Health Insurance have focused its resource in treating sever diseases such as cancer and infections. The insurance policy will gradually stop subsidizing non-life threatening medication in the future, where the patients will have to cover the cost of those non-life threatening medications. The general public's awareness of preventative medicine for the improvement of QOL has also been on the rise in recent years (e.g., obesity, diabetes prevention, erectile dysfunction, anti-aging, allergies and autoimmune remedies, and digestive health). With the aforementioned motivations, CYBiotech is aimed to provide the public with innovative medicine and supplements with the highest quality and efficiency through the principles of evidence based medicine. It is our purpose to fulfil the public's health care needs for improving their QOL.